92 related articles for article (PubMed ID: 19880713)
1. An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).
Evans DG; Wallace A
J Med Genet; 2009 Nov; 46(11):792. PubMed ID: 19880713
[No Abstract] [Full Text] [Related]
2. Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.
Evans DG; Ramsden RT; Shenton A; Gokhale C; Bowers NL; Huson SM; Pichert G; Wallace A
J Med Genet; 2007 Jul; 44(7):424-8. PubMed ID: 17307835
[TBL] [Abstract][Full Text] [Related]
3. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.
Evans DG; Moran A; King A; Saeed S; Gurusinghe N; Ramsden R
Otol Neurotol; 2005 Jan; 26(1):93-7. PubMed ID: 15699726
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis 2.
Hoa M; Slattery WH
Otolaryngol Clin North Am; 2012 Apr; 45(2):315-32, viii. PubMed ID: 22483819
[TBL] [Abstract][Full Text] [Related]
5. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
[TBL] [Abstract][Full Text] [Related]
6. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
[TBL] [Abstract][Full Text] [Related]
7. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
8. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
10. Advances in neurofibromatosis 2 (NF2): a workshop report.
Lim DJ; Rubenstein AE; Evans DG; Jacks T; Seizinger BG; Baser ME; Beebe D; Brackmann DE; Chiocca EA; Fehon RG; Giovannini M; Glazer R; Gusella JF; Gutmann DH; Korf B; Lieberman F; Martuza R; McClatchey AI; Parry DM; Pulst SM; Ramesh V; Ramsey WJ; Ratner N; Rutkowski JL; Ruttledge M; Weinstein DE
J Neurogenet; 2000 Jun; 14(2):63-106. PubMed ID: 10992163
[No Abstract] [Full Text] [Related]
11. What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?
Evans DG; Ramsden RT; Shenton A; Gokhale C; Bowers N; Huson SM; Wallace AJ
J Neurosurg; 2008 Jan; 108(1):92-6. PubMed ID: 18173316
[TBL] [Abstract][Full Text] [Related]
12. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
13. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
[TBL] [Abstract][Full Text] [Related]
14. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis.
Sestini R; Provenzano A; Bacci C; Orlando C; Genuardi M; Papi L
Genet Test; 2008 Jun; 12(2):311-8. PubMed ID: 18554169
[TBL] [Abstract][Full Text] [Related]
15. [Acustic neurinoma: correlation between clinic and MRI].
Conforti R; Faella P; Sica A; Landi N; Faggian A; Amato M; Raucci A; Scuotto A
Recenti Prog Med; 2013; 104(7-8):299-302. PubMed ID: 24042396
[TBL] [Abstract][Full Text] [Related]
16. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2.
Baser ME; Wallace AJ; Strachan T; Evans DG
J Med Genet; 2000 Jul; 37(7):542-3. PubMed ID: 10970189
[No Abstract] [Full Text] [Related]
19. Neurofibromatosis type 2 discordance in monozygous twins.
Amico S; Smith P; Tobi S; Perry M; Wallace A; Evans DG
Fam Cancer; 2020 Jan; 19(1):37-40. PubMed ID: 31965447
[TBL] [Abstract][Full Text] [Related]
20. Application of COLD-PCR for improved detection of NF2 mosaic mutations.
Paganini I; Mancini I; Baroncelli M; Arena G; Gensini F; Papi L; Sestini R
J Mol Diagn; 2014 Jul; 16(4):393-9. PubMed ID: 24815379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]